THE IMPACT OF FRAILTY ON THE EFFECTS OF EMPAGLIFLOZIN: POST-HOC ANALYSES FROM THE EMPA-KIDNEY TRIAL

https://storage.unitedwebnetwork.com/files/1099/967477096244b43de4b4e9fff568140c.pdf
THE IMPACT OF FRAILTY ON THE EFFECTS OF EMPAGLIFLOZIN: POST-HOC ANALYSES FROM THE EMPA-KIDNEY TRIAL
Kaitlin
Mayne
on behalf of the EMPA-KIDNEY Collaborative Group will.herrington@ndph.ox.ac.uk University of Oxford Nuffield Department of Population Health Oxford